Clinical impact of pharmacogenetic risk variants in a large chinese cohort
Abstract Incorporating pharmacogenetics into clinical practice promises to improve therapeutic outcomes by optimizing drug selection and dosage based on genetic factors affecting drug response. A key advantage of PGx-guided therapy is to decrease the likelihood of adverse events. To evaluate the cli...
Saved in:
Similar Items
-
The Influence of Obesity on Different Genders in Patients with Obstructive Sleep Apnea
by: Kuo-Tung Huang, et al.
Published: (2014-01-01) -
Blood pressure targets, medication consideration and unique concerns in elderly hypertension IV: Focus on frailty, orthostatic hypotension, and resistant hypertension
by: Po-Sheng Wu, et al.
Published: (2025-07-01) -
Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Southern Taiwan
by: Chih-Hao Chang, et al.
Published: (2021-09-01) -
External Validation of 3 Prediction Models for Mortality in Out‐of‐Hospital Cardiac Arrest Survivors: A Retrospective Multicenter Study
by: Chun‐Hsiang Huang, et al.
Published: (2025-08-01) -
Clinical and Economic Evaluation of a Real-Time Chest X-Ray Computer-Aided Detection System for Misplaced Endotracheal and Nasogastric Tubes and Pneumothorax in Emergency and Critical Care Settings: Protocol for a Cluster Randomized Controlled Trial
by: Chu-Lin Tsai, et al.
Published: (2025-08-01)